BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO)

CUSIP: 090572207

Q2 2025 13F Holders as of 30 Jun 2025

Security type / class
Equity / Class B Common Stock
Total 13F shares
19,201,217
Total 13F value
$4,634,744,932
Holder snapshot 6 visible 7 signals
Share change
+18,026
Put/Call ratio
332%
SEC-reported price per share
$241.32
Number of holders
380
Value change
+$3,469,914
Number of buys
162
Open additional details 1 more signal available
Number of sells
265
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
5,071,025

Security key

090572207

Report period

Q2 2025

Institutions

380

Top holders

10

BIO full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2025 Previous quarter: Q1 2025 BIO-RAD LABORATORIES, INC. SEC filings BIO-RAD LABORATORIES, INC. company facts BIO-RAD LABORATORIES, INC. 13D/G history

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of BIO - BIO-RAD LABORATORIES, INC. - Class B Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Alice N. Schwartz
Disclosed value leader
Alice N. Schwartz
Comparable rows
15/15
Latest evidence
30 Jun 2025
3/4/5 13D/G 13F Lead comparable stake: 12% 13D/G row: Alice N. Schwartz Showing 1-6 of 15 holder rows.

Quick read

Alice N. Schwartz leads the comparable SEC ownership view at 12%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Alice N. Schwartz's linked filing trail.
Comparable ownership Top 5
Alice N. Schwartz 12%
First Eagle Investment Management... 11%
VANGUARD GROUP INC 8.4%
BlackRock, Inc. 40%
Veritas Asset Management LLP 18%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Alice N. Schwartz
3/4/5 13D/G
Director Emeritus, 10%+ Owner
3/4/5 13D/G
12%
from 13D/G
$3,592,267,092
11,862,229 shares
mixed-class rows
 — 26 Aug 2024
First Eagle Investment Management, LLC
13D/G 13F
Company
13D/G 13F
11%
$657,060,173
2,528,321 shares
 +$60,827,513 30 Jun 2025
VANGUARD GROUP INC
13F 13D/G
Company · The Vanguard Group - 23-1945930
13F 13D/G
8.4%
from 13D/G
$465,724,960
1,912,157 shares
 — 31 Mar 2025
BlackRock, Inc.
13F
Company
13F
40%
$492,409,881
2,021,720 shares
 — 31 Mar 2025
Veritas Asset Management LLP
13F
Company
13F
18%
$222,399,994
913,122 shares
 — 31 Mar 2025
DIMENSIONAL FUND ADVISORS LP
13F
Company
13F
17%
$213,608,421
877,040 shares
 — 31 Mar 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
380
Shares
19,201,217
Rows available
380
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders
429
Q2 2025 holders
380
Holder diff
-49
Investor Q1 2025 Shares Q2 2025 Shares Share Diff Share Chg % Q1 2025 value Q2 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .